Find a Commonwealth Resource
Ketorolac tromethamine
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Ketorolac Tromethamine is a generic injectable nonsteroidal anti-inflammatory drug (NSAID) used for short-term management of moderate to severe pain. It is administered via intramuscular or intravenous injection in strengths like 15 mg/mL and 30 mg/mL. Manufactured by Steriscience Specialties Private Limited under ANDA 201155, this prescription medication is discontinued but was marketed starting September 2023. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Ketorolac tromethamine
Access the FDA dataset for Ketorolac tromethamine — ANDA 074802 submitted by Mylan Institutional LLC
Modified Mar 23, 2026